APR 30·StreetInsiderMed
Check-Cap ($MBAI) Advances NASDAQ Listing for MBody AI Merger
Check-Cap Ltd. (NASDAQ: $MBAI) announced that Nasdaq has completed its initial review of the listing application for its proposed merger with MBody AI Corp., with Check-Cap submitting responses to all supplementary questions. The merger is on track to close in the first half of 2026, marking a significant step towards bringing MBody AI to public markets and expanding its commercial deployments. The company anticipates being shelf-eligible for Form F-3 registration as of May 1, 2026, following the filing of its 2025 Annual Report.